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Abstract
The aim of the work was to increase the effectiveness of treatment of the severe asthma phenotype in school-age chil-
dren, taking into account the diagnostic value of atopic reactivity indicators. The study involved 30 pupils with severe asthma and 
30 children with moderate-heavy version of it. Amid severe asthma increases risk of higher concentrations of IL-4 and IL-5 in the 
serum, and almost in every second child was observed the increased concentrations of Ig E (more than 545,3 IU/mL, odds ratio 
was 1,9 (95 % CI 1,1–3,4). In the group of patients with severe asthma were significantly more frequent cases of the skin hypersen-
sitivity to household allergens with respect to the members of the second group. There were separated the indices of clinical and 
epidemiological risk and diagnostic value of some markers of atopic reactivity for verification of the severe asthma phenotype. It 
was established that the development of severe asthma in children marked tendency to reduce the metabolic activity of eosinophilic 
granulocytes in blood (in terms of intracellular content of cationic proteins and peroxidase) and phagocytic ability of these effector 
cells of allergic inflammation. For the phenotype of severe asthma the risk of high concentration of IL-4 and IL-5 in serum increased 
in 3,1 times, but this paraclinical test is rather suitable for verification of this phenotype (SP – 84,6% (95 % Sp 75,9–91,1)) than for its 
detection (Se – 36,4 % (95 % CI 26,9–46,6)).
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1. Introduction
One of the most pressing problems of modern pediatric is allergic disease in children, in-
cluding bronchial asthma (BA). According to the WHO, the prevalence of asthma among children 
is 10 %. In different regions of Ukraine this figure ranges from 5 to 9 % of child population [1, 2]. 
Particularly acute is the question of currently increasing the effectiveness of this disease therapy 
and achieve a level of control that would allow the child to lead an active social life.
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Imposing the controlling asthma therapy in children should be considered a feature of the 
phenotype, defined heterogeneous mechanisms of development, however, is almost identical clin-
ical symptoms [3, 4]. Based on the above, taking into account the performance of atopic reactiv-
ity in children that reflect the specific pathogenic mechanisms of realization of asthma [5, 6], in 
a comprehensive study of patients will personalize the treatment of asthma and thereby improve 
treatment of the disease. The aim was to increase the effectiveness of treatment of phenotype 
of the severe asthma in school-age children, taking into account the diagnostic value of atopic 
reactivity indicators.
2. Aim
The aim of the work was to increase the effectiveness of treatment of severe asthma pheno-
type in school-age children, taking into account the diagnostic value of atopic reactivity indicators.
3. Material and methods
In pulmonology department of Regional Children’s Clinical Hospital of Chernivtsy were 
complexly examined 60 school-age children suffering from asthma in remission. Over the course 
of the disease patients were divided into two clinical groups. The first (I) clinical group includ-
ed 30 patients diagnosed with severe asthma. The second (II) clinical group was formed of 30 
students, in which was defined the moderate asthma. For the main clinical signs groups of com-
parison were matched.
The first clinical group was formed of 21 boy (70,0 %) and 9 girls (30,0 %). The second 
group included 19 boys (63,3 %, Pφ>0,05) and 11 girls (36,7 %, Pφ>0,05). The average age of pa-
tients in the first group was 12,2±0,5 years, and in the second group – 11,1±0,6 years (P>0,05). The 
structure of the first clinical group included 33,3 % of the urban population and 66,7 % of patients 
from rural areas. Another group was formed of 12 persons (40,0 %) of residents of cities and urban 
areas and 18 patients (60,0 %, Pφ>0,05), who live in villages. Thus, by sex, age and place of resi-
dence clinical comparison group did not differ significantly.
Eosinophilic metabolic activity of white blood cells was determined by intracellular content 
of cationic protein (in S. U.) method by V. E. Piharevskoho, peroxidase (in S. U.) – by the method 
of Graham-Knoll [7]. As indicators of the functional state of eosinophilic white blood cells was de-
termined their phagocytic activity (FA, %) by Mosyahinoyi YE. N. method. The contents of serum 
total immunoglobulin E (IgE), interleukin-4 (IL-4) and interleukin-5 (IL-5) were determined by 
enzyme-linked immunosorbent assay (ELISA). Determination of immediate type skin sensitivity 
to allergens Nonbacterial standard was performed by intradermal tests. To study the atopy was 
used a standard household, epidermal, pollen and food allergens.
Statistical analysis of the results of research was carried out by methods of variation statis-
tics using statistical program StatSoft Statistica v5.0., and from the perspective of clinical epidemi-
ology determining sensitivity (Se) and specificity (Sp) test and positive (LR+) and negative (LR–) 
likelihood ratio, as well as the absolute (AR), relative (RR) risks and odds ratios (OR) indicating 
95 % confidence interval (95 % CI).
4. The results of the study
The indicators of eosinophilic intracellular cytotoxic substances in children at observation 
are shown in Table 1.
Table 1
The indicators of intracellular eosinophilic cationic protein (ECP) and peroxidase (EP) in children 
of comparison group
Clinical group Number of children ECP, S. U. EP, S. U.
І 30 0,17±0,03 1,32±0,04
ІІ 30 0,26±0,02 1,43±0,02 
P: І:II <0,05 <0,05
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The evaluation of phagocytic activity of eosinophilic granulocytes in blood between the groups 
revealed significant differences in observations. Since, in patients of I clinical group medium group 
index FA of blood eosinophils was 65,8±2,8 %, while in patients of II group – 74,0±2,4 (p<0,05). 
The level of FA eosinophilic leukocytes less than 65 % was observed in 69,2±7,4 % of children with 
severe asthma, and in 38,8±8,1 % of patients with a moderate form of the disease (pφ<0,05). Reduced 
to above the level of FA blood eosinophils associated with the risk of the presence of severe asthma 
phenotype as follows: RR – 2,1 [95 % CI: 1,4–2,5], AR – 0,4 – odds ratio – 3,6 [ 95 % CI: 2,1–6,3].
Comparative analysis of the IL-4 and IL-5 concentration in serum of clinical students in both 
groups revealed no differences likely, however, marked a half of growth in single patients with se-
vere asthma. Thus, the average concentration of IL-4 in serum of children in first clinical group was 
10,6±2,1 pg/ml, and in those of the second group – 7,2±2,5 pg/ml (p>0,05). The average content of 
interleukin-5 in the clinical group was 35,8±15,7 pg/ml and 8,6±4,3 pg/ml (p>0,05), respectively, and 
testified four times a day in excess of the marker of first clinical group. Despite the lack of significant 
differences of these cytokines concentration in the blood serum of children in the comparison groups, 
nearly in one of three patients (36,4 %) on the phenotype of severe asthma was recorded significantly 
increased content of IL-4 (more than 10,0 pg/ml), while in patients of the second group – only 15,5 % 
of cases (pφ <0,05). This specificity of the above concentrations of IL-4 in peripheral blood of pupils 
as the verification test of severe asthma phenotype was 84,6 % (95 % CI 75,9–91,1), but sensitivity – 
only 36,4 % (95 % CI 26,9–46,6), the odds ratio was 3,1 (95 % CI 1,5–6,2). On the one hand, it high-
lights the presence of other inflammatory sub phenotype in children with severe asthma phenotype, 
and the other one the high specificity of this test in the verification of asthma-phenotype.
It is established that the content of total Ig E in serum in all virtually surveyed patients (95,1 %) 
is higher than in the normal population of healthy children (120 IU/ml), but in patients of the first 
clinical group it was somewhat higher. Thus, the concentration of total immunoglobulin E in serum 
of pupils with severe asthma was 813,5 IU/ml, and in those of other clinical groups was 685,3 IU/ml 
(p>0,05). Whey content of total IgE, which exceeded 545,3 IU/ml, was recorded in 56,6 % of children 
of first clinical group and only in 43,4 % of the second (p>0,05) comparison group.
In conducting intradermal allergy tests was revealed that in patients of the first group most 
often occurs increased sensitivity to household allergens and pollen, while children in other clinical 
groups – to food allergens (Fig. 1).
Fig. 1. Skin sensitivity (size of the papules) to allergens in clinical group children
It should be noted that severe asthma more likely associates with the presence of increased 
skin sensitivity to household allergens. Thus, the amount of congestion in the sample household aller-
gens more than 15,0 mm was recorded in 81,5 % of children in the first group and only in 51,9 % of 
persons (pφ<0,05) from the second one.
Performance of diagnostic value of increased skin sensitivity to household allergens as the ver-
ification test phenotype of severe asthma, was as follows: sensitivity – 81,5 % (95 % CI 72,5–88,5), 
specificity – 48,1 % (95 % CI 37,9–58,4) LR + – 1,5 and LR – 0,3. Increased sensitivity to domestic 
allergens (hyperemia more than 15,0 mm) associated with the risk of having severe asthma pheno-
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type as follows: attributive risk – 0,3, the relative risk was equal to 2,2 (95 % CI 1,7–2,7), at odds 
ratio – 4,1 (95 % CI 2,1–7,7).
5. Discussion
According to the literature in almost half of patients (40–60 % according to different au-
thors) [1, 8] developed asthma that is difficult to treat. It is believed that the inefficiency of con-
trolling asthma therapy [3], due, in particular, to the presence of different asthma phenotypes, such 
phenotype as “severe asthma” [5, 9, 10].
Clinical phenotypes of severe asthma need a lot of attention because 80 % of the total cost 
of asthma accounts is for patients suffering from its severe form [11]. As a result of current multi-
center study it is known that severe asthma is independent phenotype of the disease, which has only 
its inherent characteristics [12]. Analysis of outputs and asthma symptoms study «The Melbourne 
Asthma Study» showed the heavier asthma in child, the less chance of remission in adults [13, 14]. 
According to many contemporary researchers phenotype of severe asthma in children is unique; it 
is different from the phenotype of mild and moderate asthma and severe asthma from adult clinical 
and functional parameters, biological markers of inflammation, in response to therapy and prog-
nosis [15].
Based on current published data that damaging effect eosinophilic polymorphonuclear leu-
kocytes implemented by degranulation and the release of extracellular space in specific aggres-
sive substances, particularly cationic proteins and peroxidase [14, 15], we thought it appropriate 
to determine the intracellular content of these substances in the blood eosinophilic granulocytes 
children in the comparison group to assess their clinical significance in detecting severe asthma 
compared to moderate option.
In children with severe asthma phenotype intracellular content of eosinophilic cationic pro-
tein and peroxidase was significantly lower in relation to patients with moderate asthma. The re-
sults may indicate that eosinophilic white blood cells as key effector cells of allergic inflammation, 
take an active part in the implementation of severe asthma in children with increased needs for 
cytotoxicity through their active degranulation.
The differences in the main marker phagocytosis, in our opinion, involved more confirmed 
eosinophilic granulocytes in the blood of allergic inflammation by severe asthma and eosinophilic 
exhaustion of functional activity of leukocytes in the persistence of severe inflammation.
Important indicators of chronic inflammation in asthma is the content of serum IL-4 and 
IL-5, the biological effects are associated with the regulation of the synthesis of immunoglobulin 
E and support eosinophilic inflammation in the respiratory tract [16, 17]. Since the development of 
asthma always associated with congenital, genetic determination hyper IgE [16, 18, 19], we studied 
its contents in serum of examined children.
Thus, in most patients with severe asthma was observed high concentration of immunoglob-
ulin E, IL-4 and -5 in the serum that indirectly reflects the severity of inflammation in this cohort 
of people. The trend to higher content of interleukin –4 and –5 in serum of children with severe 
asthma, which is found in the study, due probably to the expressive airway inflammation [20].
In conducting intradermal allergy tests was revealed significantly higher sensitivity in chil-
dren with severe asthma, which coincides with the opinion of some scholars [21] who believe that 
the leading mechanism of this phenotype of asthma – atopic one.
6. Conclusion
1. With the development of severe asthma in children was marked tendency to reduce the 
metabolic activity of eosinophilic granulocytes of blood (in terms of intracellular content of cation-
ic proteins and peroxidase) and phagocytic ability of these effector cells of allergic inflammation.
2. For the phenotype of severe asthma in 3,1 times increased the risk of high concentration 
of IL-4 and IL-5 in serum, but this paraclinical test rather suitable for verification of this phenotype 
(SP – 84,6 % (95 % Sp 75,9–91,1)) than for its detection (Se – 36,4 % (95 % CI 26,9–46,6)).
3. Concentration of total immunoglobulin E in serum exceeding 545,3 IU/ml in 2 times 
increased the chances of the presence of severe asthma in children.
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4. Increased sensitivity to domestic allergens (hyperemia more than 15,0 mm) allows to 
verify the specificity 81,5 % of severe asthma and personalize treatment policy in these patients.
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